Morpholine derivatives as norepinephrine reuptake inhibitors
申请人:Eli Lilly and Company
公开号:EP2223916A1
公开(公告)日:2010-09-01
Compounds of the general formula (I)
are inhibitors of the reuptake of norepinephrine. As such, they may be useful for the treatment of disorders of the central and/or peripheral nervous system.
[EN] TREATMENT OF HOT FLASHES, IMPULSE CONTROL DISORDERS AND PERSONALITY CHANGE DUE TO A GENERAL MEDICAL CONDITION<br/>[FR] TRAITEMENT DES BOUFFEES DE CHALEUR, DES TROUBLES DU CONTROLE DES IMPULSIONS ET DU CHANGEMENT DE PERSONNALITE CONSECUTIFS A UN ETAT PATHOLOGIQUE GENERAL
申请人:LILLY CO ELI
公开号:WO2005060949A2
公开(公告)日:2005-07-07
Selective norepinephrine reuptake inhibitors are useful for the prevention or treatment of hot flashes, vasomotor symptoms, impulse control disorders or personality change due to a general medical condition.